Target intelligence / Profile preview

Type III secretion system ATPase (SctN)

Target
SctN
Molecular classification
Enzyme, ATPase, AAA+ ATPase, Virulence factor, Bacterial protein export component
01

Overview

The Type III secretion system (T3SS) ATPase is a highly conserved enzyme essential for the virulence of many Gram-negative pathogens, including Salmonella, Shigella, and Pseudomonas [1.4.3]. It belongs to the AAA+ family of ATPases and provides the energy required for the unfolding and translocation of effector proteins through the needle-like injectisome into host cells [1.3.5, 1.4.3]. In the flagellar system, the homologous ATPase (FliI) drives the export of flagellar subunits necessary for bacterial motility [1.2.1, 1.4.1]. Because these ATPases are critical for pathogenesis but not for bacterial survival under standard conditions, they are attractive targets for anti-virulence therapies that neutralize pathogens without exerting the strong selective pressure associated with traditional antibiotics [1.3.1, 1.3.5]. Small molecule inhibitors, such as salicylidene acylhydrazides and novel non-competitive inhibitors, have shown promise in blocking ATPase activity and reducing the secretion of virulence factors in various infection models [1.3.3, 1.3.5]. Targeting this enzyme offers a strategy to treat infections while potentially reducing the development of antibiotic resistance [1.3.1].

Other names
FliIEscNSpa47InvCYscNHrpB6VscNBsaSHrcNFlagellar export ATPaseType III secretion system protein N
02

Mechanism of action

Inhibition of ATP hydrolysis and energy coupling to the T3SS export gate, preventing the secretion of virulence effector proteins [1.3.1, 1.3.3].

03

Biological functions

ATP hydrolysisProtein secretionFlagellar assemblyEffector protein unfoldingChaperone releaseSubstrate switching
04

Disease associations

InfectionBacterial pathogenesisGastroenteritisRespiratory infectionSepsis
05

Safety considerations

Selectivity over human mitochondrial F1F0-ATPasePotential disruption of commensal bacterial motilityOff-target effects on other human ATPases (e.g., V-ATPase)
06

Interacting drugs

Salicylidene acylhydrazides

3 more in the full profile.

07

Biomarkers

Effector protein secretion levels (e.g., IpaB, IpaC, EspA, EspB)Bacterial motility (for flagellar ATPase)Host cell cytotoxicity (e.g., LDH release)Bacterial load in host tissues

Beyond the preview

Go deeper on Type III secretion system ATPase (SctN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type III secretion system ATPase (SctN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call